Position in BIOA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,799,050
New position
Shares Held
155,000
first reported quarter
Ownership
0.338%
of shares outstanding
% of Portfolio
1.30%
of 13F equity value
Holder Rank
#44
of 150 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in BIOA
reported options exposure · as of Jun 30, 2026CallValue
$6,127,500
CallShares
250,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Squadron Capital Management LLC holds $7,383,317 across 3 Drug Manufacturers - Specialty & Generic names. BIOA ranks #1 (51.5% of the industry book) .
All Filings in BIOA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,799,050 | 155,000 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $6,127,500 | 250,000 | Call | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||